retatrutide ישראל התרופה החדשה שמבטיחה ירידה של 30% במשקל – אך מעוררת חשש בקרב הרופאים Retatrutide, an experimental weight-loss drug,

When Will Retatrutide Be Available to the Public

These medications offer the same active ingredients as FDA-approved drugs but come at a more affordable price

Lose 15% of your body weight with GLP-1s * Lose 15% of your body weight with GLP-1s * *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group

This corresponds to a natural circadian trough that exists independent of medication

How Retatrutide Compares to Other GLP-1 Medications Retatrutide differs from earlier GLP-1 medications in its mechanism

It stops them from multiplying